1. Manabe O, Koyanagawa K, Hirata K, Oyama-Manabe N, Ohira H, Aikawa T, Furuya S, Naya M, Tsujino I, Tomiyama Y, Otaki Y, Anzai T, Tamaki N. Prognostic Value of (18)F-FDG PET Using Texture Analysis in Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2020 Apr;13(4):1096-1097. doi: 10.1016/j.jcmg.2019.11.021. Epub 2020 Jan 15. PubMed PMID: 31954654.
  2. Takahashi K, Nakamura J, Sakiyama S, Nakaya T, Sato T, Watanabe T, Ohira H, Makita K, Tomaru U, Ishizu A, Tsujino I. A histopathological report of a 16-year-old male with peripheral pulmonary artery stenosis and Moyamoya disease with a homozygous RNF213 mutation. Respir Med Case Rep. 2019 Dec 14;29:100977. doi: 10.1016/j.rmcr.2019.100977. eCollection 2020. PubMed PMID: 31908915; PubMed Central PMCID: PMC6938952.
  3. Furuya S, Naya M, Manabe O, Hirata K, Ohira H, Aikawa T, Koyanagawa K, Magota K, Tsujino I, Anzai T, Kuge Y, Oyama-Manabe N, Kudo K, Shiga T, Tamaki N. (18)F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis. J Nucl Cardiol. 2019 Dec 9. doi: 10.1007/s12350-019-01976-6. [Epub ahead of print] PubMed PMID: 31820409.
  4. Koyanagawa K, Naya M, Aikawa T, Manabe O, Furuya S, Kuzume M, Oyama-Manabe N, Ohira H, Tsujino I, Anzai T. The rate of myocardial perfusion recovery after steroid therapy and its implication for cardiac events in cardiac sarcoidosis and primarily preserved left ventricular ejection fraction. J Nucl Cardiol. 2019 Oct 11. doi: 10.1007/s12350-019-01916-4. [Epub ahead of print] PubMed PMID: 31605274.
  5. Abe N, Kato M, Kono M, Fujieda Y, Ohira H, Tsujino I, Oyama-Manabe N, Oku K, Bohgaki T, Yasuda S, Atsumi T. Right ventricular dimension index by cardiac magnetic resonance for prognostication in connective tissue diseases and pulmonary hypertension. Rheumatology (Oxford). 2020 Mar 1;59(3):622-633. doi: 10.1093/rheumatology/kez336. PubMed PMID: 31424519.
  6. Ninagawa K, Kato M, Nakamura H, Abe N, Kono M, Fujieda Y, Oku K, Yasuda S, Ohira H, Tsujino I, Atsumi T. Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis. Rheumatol Int. 2019 Nov;39(11):1883-1887. doi: 10.1007/s00296-019-04370-0. Epub 2019 Jul 6. PubMed PMID: 31280357.
  7. Tanimura S, Kato M, Abe N, Ohira H, Tsujino I, Atsumi T. Successful treatment of tocilizumab-resistant large vessel pulmonary arteritis with infliximab. Immunol Med. 2018 Mar;41(1):39-42. doi: 10.1080/09114300.2018.1451616. Epub 2018 Apr 3. PubMed PMID: 30938259.
  8. Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, Ito H, Kuwana M, Matsubara H, Momomura SI, Nishimura M, Ogino H, Satoh T, Shimokawa H, Yamauchi-Takihara K, Tatsumi K, Ishibashi-Ueda H, Yamada N, Yoshida S, Abe K, Ogawa A, Ogo T, Kasai T, Kataoka M, Kawakami T, Kogaki S, Nakamura M, Nakayama T, Nishizaki M, Sugimura K, Tanabe N, Tsujino I, Yao A, Akasaka T, Ando M, Kimura T, Kuriyama T, Nakanishi N, Nakanishi T, Tsutsui H; Japanese Circulation Society and the Japanese Pulmonary Circulation and Pulmonary Hypertension Society Joint Working Group. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017). Circ J. 2019 Mar 25;83(4):842-945. doi: 10.1253/circj.CJ-66-0158. Epub 2019 Mar 9. PubMed PMID: 30853682.
  9. Koyanagawa K, Naya M, Aikawa T, Manabe O, Kuzume M, Ohira H, Tsujino I, Tamaki N, Anzai T. Prognostic value of phase analysis on gated single photon emission computed tomography in patients with cardiac sarcoidosis. J Nucl Cardiol. 2019 Feb 27. doi: 10.1007/s12350-019-01660-9. [Epub ahead of print] PubMed PMID: 30815835.
  10. Sato K, Ohira H, Horinouchi T, Nakaya T, Mazaki Y, Sugimoto A, Watanabe T, Tsujino I, Nishimura M. Chinese herbal medicine Qing-Dai-induced pulmonary arterial hypertension in a patient with ulcerative colitis: A case report and experimental investigation. Respir Med Case Rep. 2019 Feb 8;26:265-269. doi: 10.1016/j.rmcr.2019.02.007. eCollection 2019. PubMed PMID: 30815357; PubMed Central PMCID: PMC6378840.
  11. Togo R, Hirata K, Manabe O, Ohira H, Tsujino I, Magota K, Ogawa T, Haseyama M, Shiga T. Cardiac sarcoidosis classification with deep convolutional neural network-based features using polar maps. Comput Biol Med. 2019 Jan;104:81-86. doi: 10.1016/j.compbiomed.2018.11.008. Epub 2018 Nov 12. PubMed PMID: 30447397.
  12. Manabe O, Ohira H, Hirata K, Hayashi S, Naya M, Tsujino I, Aikawa T, Koyanagawa K, Oyama-Manabe N, Tomiyama Y, Magota K, Yoshinaga K, Tamaki N. Use of (18)F-FDG PET/CT texture analysis to diagnose cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1240-1247. doi: 10.1007/s00259-018-4195-9. Epub 2018 Oct 16. PubMed PMID: 30327855.
  13. Furuya S, Manabe O, Ohira H, Hirata K, Aikawa T, Naya M, Tsujino I, Koyanagawa K, Anzai T, Oyama-Manabe N, Shiga T. Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy? EJNMMI Res. 2018 Oct 5;8(1):94. doi: 10.1186/s13550-018-0447-8. PubMed PMID: 30291527; PubMed Central PMCID: PMC6173675.
  14. Tanabe N, Kawakami T, Satoh T, Matsubara H, Nakanishi N, Ogino H, Tamura Y, Tsujino I, Ogawa A, Sakao S, Nishizaki M, Ishida K, Ichimura Y, Yoshida M, Tatsumi K. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: A systematic review. Respir Investig. 2018 Jul;56(4):332-341. doi: 10.1016/j.resinv.2018.03.004. Epub 2018 Jul 3. PubMed PMID: 30008295.
  15. Nakaya T, Tsujino I, Ohira H, Sato T, Watanabe T, Oyama-Manabe N, Nishimura M. Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy. Pulm Circ. 2018 Apr-Jun;8(2):2045894018765350. doi: 10.1177/2045894018765350. Epub 2018 Feb 28. PubMed PMID: 29488427; PubMed Central PMCID: PMC5858733.
  16. Nakamura H, Kato M, Nogochi A, Ohira H, Tsujino I, Atsumi T. Efficient detection of pulmonary arterial hypertension using serum haptoglobin level and cardiac MRI in patients with connective tissue diseases: a pilot study. Clin Exp Rheumatol. 2018 Mar-Apr;36(2):345-346. Epub 2018 Feb 15. PubMed PMID: 29465376.
  17. Shoji T, Mizugaki H, Ikezawa Y, Furuta M, Takashima Y, Kikuchi H, Goudarzi H, Asahina H, Kikuchi J, Kikuchi E, Sakakibara-Konishi J, Shinagawa N, Tsujino I, Nishimura M. Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor Shrinkage. Intern Med. 2018 Jun 15;57(12):1769-1772. doi: 10.2169/internalmedicine.9741-17. Epub 2018 Feb 9. PubMed PMID: 29434159; PubMed Central PMCID: PMC6047974.
  18. Sato T, Tsujino I, Ohira H, Oyama-Manabe N, Ito YM, Takashina C, Watanabe T, Nishimura M. Accuracy of echocardiographic indices for serial monitoring of right ventricular systolic function in patients with precapillary pulmonary hypertension. PLoS One. 2017 Nov 9;12(11):e0187806. doi: 10.1371/journal.pone.0187806. eCollection 2017. PubMed PMID: 29121072; PubMed Central PMCID: PMC5679547.
  19. Shimizu K, Tsujino I, Sato T, Sugimoto A, Nakaya T, Watanabe T, Ohira H, Ito YM, Nishimura M. Performance of computed tomography-derived pulmonary vasculature metrics in the diagnosis and haemodynamic assessment of pulmonary arterial hypertension. Eur J Radiol. 2017 Nov;96:31-38. doi: 10.1016/j.ejrad.2017.09.010. Epub 2017 Sep 19. PubMed PMID: 29103472.
  20. Ohira H, Mc Ardle B, deKemp RA, Nery PB, Juneau D, Renaud JM, Klein R, Clarkin O, MacDonald K, Leung E, Nair G, Beanlands RS, Birnie D. Inter- and Intra- observer agreement of FDG-PET/CT image interpretation in patients referred for assessment of Cardiac Sarcoidosis. J Nucl Med 2017; 58 (8): 1324-29.
  21. Ohira H, Yoshinaga K, Manabe O, Oyama-Manabe N, Tsujino I, Nishimura M, Tamaki N. Clinical Application of 18F-fluorodeoxyglucose PET and LGE CMR in Cardiac Sarcoidosis. Annals of Nuclear Cardiology 2017; 3(1): 125-130.
  22. Ogawa A, Satoh T, Fukuda T, Sugimura K, Fukumoto Y, Emoto N, Yamada N, Yao A, Ando M, Ogino H, Tanabe N, Tsujino I, Hanaoka M, Minatoya K, Ito H, Matsubara H. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry. Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11). pii: e004029. doi: 10.1161/CIRCOUTCOMES.117.004029. PubMed PMID: 29101270.
  23. Nakamura H, Kato M, Nakaya T, Kono M, Tanimura S, Sato T, Fujieda Y, Oku K, Ohira H, Bohgaki T, Yasuda S, Tsujino I, Nishimura M, Atsumi T. Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study. Medicine (Baltimore). 2017 Oct;96(43):e8349. doi: 10.1097/MD.0000000000008349. PubMed PMID: 29069014; PubMed Central PMCID: PMC5671847.
  24. Tamura Y, Kumamaru H, Satoh T, Miyata H, Ogawa A, Tanabe N, Hatano M, Yao A, Abe K, Tsujino I, Fukuda K, Kimura H, Kuwana M, Matsubara H, Tatsumi K; Japan PH Registry (JAPHR) Network. Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension. Circ J. 2017 Dec 25;82(1):275-282. doi: 10.1253/circj.CJ-17-0139. Epub 2017 Jul 26. PubMed PMID: 28747612.
  25. Noguchi A, Tsujino I, Oyama-Manabe N, Tanino M. Replacement myocardial fibrosis at the site of late gadolinium enhancement on magnetic resonance imaging in a patient with diffuse cutaneous systemic sclerosis: An autopsy report. J Cardiol Cases. 2017 May 13;16(2):48-51. doi: 10.1016/j.jccase.2017.04.005. eCollection 2017 Aug. PubMed PMID: 30279795; PubMed Central PMCID: PMC6149262.
  26. Aikawa T, Oyama-Manabe N, Naya M, Ohira H, Sugimoto A, Tsujino I, Obara M, Manabe O, Kudo K, Tsutsui H, Tamaki N. Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study. Eur Radiol. 2017 Oct;27(10):4054-4063. doi: 10.1007/s00330-017-4824-x. Epub 2017 Apr 5. PubMed PMID: 28382537.
  27. Sato T, Ohira H, Tsujino I. Representative Chest Auscultation Findings in Pulmonary Hypertension: Phonocardiograms and Sound Clips. Ann Am Thorac Soc. 2017 May;14(5):e1-e3. doi: 10.1513/AnnalsATS.201612-1031LE. PubMed PMID: 28253449.
  28. Sato T, Tsujino I, Sugimoto A, Nakaya T, Watanabe T, Ohira H, Suzuki M, Konno S, Oyama-Manabe N, Nishimura M. The effects of pulmonary vasodilating agents on right ventricular parameters in severe group 3 pulmonary hypertension: a pilot study. Pulm Circ. 2016 Dec;6(4):524-531. doi: 10.1086/688712. PubMed PMID: 28090294; PubMed Central PMCID: PMC5210053.
  29. Noguchi A, Kato M, Kono M, Ohmura K, Ohira H, Tsujino I, Oyama-Manabe N, Oku K, Bohgaki T, Horita T, Yasuda S, Nishimura M, Atsumi T. Bi-ventricular interplay in patients with systemic sclerosis-associated pulmonary arterial hypertension: Detection by cardiac magnetic resonance. Mod Rheumatol. 2017 May;27(3):481-488. doi: 10.1080/14397595.2016.1218597. Epub 2016 Aug 18. PubMed PMID: 27535805.
  30. Ohira H, Promislow S, Clarkin O, Ruddy TD, Beanlands RS, Chow BJ.How to Write a Good Myocardial Perfusion Imaging Report: Current North American Reports. Ann Nucl Cardiol 2016; 2(1): 162-166.
  31. Ohira H, deKemp R, Pena E, Davies RA, Stewart DJ, Chandy G, Contreras-Dominguez V, Dennie C, Mc Ardle B, Mc Klein R, Renaud JM, DaSilva JN, Pugliese C, Dunne R, Beanlands R, Mielniczuk LM. Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response. Eur Heart J Cardiovasc Imaging 2016; 17 (12): 1424-31.
  32. Watanabe T, Tsujino I, Konno S, Ito YM, Takashina C, Sato T, Isada A, Ohira H, Ohtsuka Y, Fukutomi Y, Nakamura H, Kawagishi Y, Okada C, Hizawa N, Taniguchi M, Akasawa A, Nishimura M. Association between Smoking Status and Obesity in a Nationwide Survey of Japanese Adults. PLoS One. 2016 Mar 23;11(3):e0148926. doi: 10.1371/journal.pone.0148926. eCollection 2016. PubMed PMID: 27007232; PubMed Central PMCID: PMC4805304.
  33. Takashina C, Tsujino I, Watanabe T, Sakaue S, Ikeda D, Yamada A, Sato T, Ohira H, Otsuka Y, Oyama-Manabe N, Ito YM, Nishimura M. Associations among the plasma amino acid profile, obesity, and glucose metabolism in Japanese adults with normal glucose tolerance. Nutr Metab (Lond). 2016 Jan 19;13:5. doi: 10.1186/s12986-015-0059-5. eCollection 2016. PubMed PMID: 26788116; PubMed Central PMCID: PMC4717594.
  34. Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):259-269. doi: 10.1007/s00259-015-3181-8. Epub 2015 Sep 11. PubMed PMID: 26359191.
  35. Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, Yamada A, Oyama-Manabe N, Hirata K, Nishimura M, Tamaki N. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016 Apr;23(2):244-52. doi: 10.1007/s12350-015-0226-0. Epub 2015 Aug 5. PubMed PMID: 26243179; PubMed Central PMCID: PMC4785205.
  36. Tanabe N, Taniguchi H, Tsujino I, Sakamaki F, Emoto N, Kimura H, Takamura K, Hanaoka M, Nishimura M, Tatsumi K; JRS Lung Disease PH Study Group. Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases. Respirology. 2015 Jul;20(5):805-12. doi: 10.1111/resp.12530. Epub 2015 Mar 31. PubMed PMID: 25828844.
  37. Sato T, Tsujino I, Ohira H, Oyama-Manabe N, Ito YM, Yamada A, Ikeda D, Watanabe T, Nishimura M. Right atrial volume and reservoir function are novel independent predictors of clinical worsening in patients with pulmonary hypertension. J Heart Lung Transplant. 2015 Mar;34(3):414-23. doi: 10.1016/j.healun.2015.01.984. Epub 2015 Feb 7. PubMed PMID: 25813768.
  38. Ohira H, Beanlands RS, Davies RA, Mielniczuk L. The role of nuclear imaging in pulmonary hypertension. J. Nucl Cardiol. 2015; 22(1): 141-57.